Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-7436 for chemotherapy-induced nausea and vomiting
NCT00212602Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Ono Pharmaceutical. Started Aug 2005; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00212602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212602.